Your browser doesn't support javascript.
loading
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma.
Mai, Elias K; Huhn, Stefanie; Miah, Kaya; Poos, Alexandra M; Scheid, Christof; Weisel, Katja C; Bertsch, Uta; Munder, Markus; Berlanga, Oscar; Hose, Dirk; Seckinger, Anja; Jauch, Anna; Blau, Igor W; Hänel, Mathias; Salwender, Hans J; Benner, Axel; Raab, Marc S; Goldschmidt, Hartmut; Weinhold, Niels.
Afiliação
  • Mai EK; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Huhn S; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Miah K; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
  • Poos AM; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Scheid C; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Weisel KC; Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany.
  • Bertsch U; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Munder M; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
  • Berlanga O; National Center for Tumor Diseases (NCT) Heidelberg, Heidelberg, Germany.
  • Hose D; Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany.
  • Seckinger A; The Binding Site Group Ltd, Birmingham, United Kingdom.
  • Jauch A; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium.
  • Blau IW; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, Belgium.
  • Hänel M; Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany.
  • Salwender HJ; Medical Clinic, Charité University Medicine Berlin, Berlin, Germany.
  • Benner A; Department of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.
  • Raab MS; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany.
  • Goldschmidt H; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Weinhold N; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.
Blood Cancer J ; 13(1): 1, 2023 01 04.
Article em En | MEDLINE | ID: mdl-36599831
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Blood Cancer J Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha